BBP

Virtus LifeSci Biotech Products ETF [BBP] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

BBP Stock Summary

Top 10 Correlated ETFs

BBP

Top 10 Correlated Stocks

BBP

In the News

BBP Financial details

Company Rating
-
Market Cap
19.41M
Income
-
Revenue
-
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
3.61%
SMA50
9.3%
SMA100
22.77%
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
45.0-63.25
52W High
+15.87%
52W Low
+62.21%
RSI
54.17
Rel Volume
0.32
Avg Volume
3.35K
Volume
1.09K
Perf Week
0.63%
Perf Month
4.58%
Perf Quarter
37.16%
Perf Half Y
26.22%
-
-
-
-
Beta
0.65
-
-
Volatility
0.66%, 1.6%
Prev Close
-1.01%
Price
72.995
Change
-1.91%

Something similar

Top by Market Cap
AMZ.DE
1YD.DE
LLY.SW
0YXG.L
VOO
Top Correlated ETFs
IBB
BIB
IDNA
IBBQ
PINK
Top Correlated Stocks
AMEQ.DE
FSPHX
SHSCX
SHSKX
SHSSX
Similar Market Cap
RWVG
INRD
VICEROY.NS
POLY.ST
DFHY

Company Profile

Financial Services Asset Management
  • Volume Average 3.35K
  • Market Capitalization 19.41M
  • Headquarters US
  • IPO Date 2014-12-17

Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration ("FDA") for marketing.